Dr. Blevins Corner
Medical comments from Dr. Lewis Blevins MD. Director Center for Pituitary Disorders at University California San Francisco
Follow ups: Why are they so critical?
Two cases where patients’ lack of follow-up leads to complications that likely could have been avoided.
Inquiries
Interesting inquiries prompted by the questions patients leave in their health portals.
A pituitary patient’s experience with COVID-19
A compelling, detailed account of a pituitary patient’s experience with COVID-19 everyone should listen. As the virus takes hold in what is undoubtedly the worst phase of this pandemic, we urge you to follow all
Telemedicine and COVID-19, insights from our survey
Not surprisingly, COVID-19 appears to have significantly impacted pituitary patients’ access to healthcare. Our brief survey elicited information from respondents on their experiences and attitudes towards obtaining healthcare via telemedicine. Dr. Blevins shares the findings
The unrecognized caveats of pituitary conditions
From Lewis S Blevins, Jr., M.D. – Today on Dr. Blevins’ Corner: An elderly man underwent removal of the thyroid gland many years ago due to an overactive thyroid as a result of a goiter. He
The things to take into consideration in interpreting pituitary lab results
In this eye-opening podcast, Dr. Lewis Blevins takes an in-depth look at the science of interpreting pituitary lab results and shares some of the things physicians think about when viewing results. Here’s an excerpt of
A discussion on telemedicine and pituitary disease
Important changes in telehealth visit regulations provide an excellent opportunity for patients to receive consultations from highly experienced specialists in pituitary disease. Read on! On Monday, November 16, 2020, doctors Lewis Blevins and Sandeep Kunwar
The effects of COVID-19 on pituitary patients’ usage and access to healthcare
From J D Faccinetti and Lewis S Blevins, M.D. cofounders – Our focus today is on the effects of COVID-19 on pituitary patients’ access to, and utilization of healthcare as the pandemic continues to affect
A tale of two patients: the biology of different pituitary tumors
Two patients with residual pituitary tumors and their unpredictable differences.
Telemedicine: adapting to change
Telemedicine, how practices have adapted, views on pros and cons, and how things may change in the future.
Pituitary MRI educational series: An unusual case of hyperprolactinemia
Endocrine News, the leading magazine for endocrinologists tunes into PWN podcast
Endocrine News tuned into a Pituitary World News podcast to hear two neuroendocrinologists discuss treatment options for COVID-19 patients with underlying pituitary conditions Here’s an excerpt. “The ongoing COVID-19 pandemic brings an unprecedented kind of